These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26065007)

  • 1. Innate and Adaptive Immunity in Calcific Aortic Valve Disease.
    Mathieu P; Bouchareb R; Boulanger MC
    J Immunol Res; 2015; 2015():851945. PubMed ID: 26065007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and adaptive immunity: the understudied driving force of heart valve disease.
    Bartoli-Leonard F; Zimmer J; Aikawa E
    Cardiovasc Res; 2021 Nov; 117(13):2506-2524. PubMed ID: 34432007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive immune cells in calcific aortic valve disease.
    Raddatz MA; Madhur MS; Merryman WD
    Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H141-H155. PubMed ID: 31050556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.
    Mahmut A; Boulanger MC; Bouchareb R; Hadji F; Mathieu P
    Cardiovasc Res; 2015 Apr; 106(1):109-20. PubMed ID: 25644539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis.
    Meng X; Ao L; Song Y; Babu A; Yang X; Wang M; Weyant MJ; Dinarello CA; Cleveland JC; Fullerton DA
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C29-35. PubMed ID: 17942642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease.
    El Husseini D; Boulanger MC; Mahmut A; Bouchareb R; Laflamme MH; Fournier D; Pibarot P; Bossé Y; Mathieu P
    J Mol Cell Cardiol; 2014 Jul; 72():146-56. PubMed ID: 24631773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin receptor blockers are associated with reduced fibrosis and interleukin-6 expression in calcific aortic valve disease.
    Côté N; Mahmut A; Fournier D; Boulanger MC; Couture C; Després JP; Trahan S; Bossé Y; Pagé S; Pibarot P; Mathieu P
    Pathobiology; 2014; 81(1):15-24. PubMed ID: 23969418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation is associated with the remodeling of calcific aortic valve disease.
    Coté N; Mahmut A; Bosse Y; Couture C; Pagé S; Trahan S; Boulanger MC; Fournier D; Pibarot P; Mathieu P
    Inflammation; 2013 Jun; 36(3):573-81. PubMed ID: 23225202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.
    Mahmut A; Boulanger MC; El Husseini D; Fournier D; Bouchareb R; Després JP; Pibarot P; Bossé Y; Mathieu P
    J Am Coll Cardiol; 2014 Feb; 63(5):460-9. PubMed ID: 24161325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of TLR3 induces osteogenic responses in human aortic valve interstitial cells through the NF-κB and ERK1/2 pathways.
    Zhan Q; Song R; Zeng Q; Yao Q; Ao L; Xu D; Fullerton DA; Meng X
    Int J Biol Sci; 2015; 11(4):482-93. PubMed ID: 25798067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
    Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
    J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathway.
    Nsaibia MJ; Boulanger MC; Bouchareb R; Mkannez G; Le Quang K; Hadji F; Argaud D; Dahou A; Bossé Y; Koschinsky ML; Pibarot P; Arsenault BJ; Marette A; Mathieu P
    Cardiovasc Res; 2017 Sep; 113(11):1351-1363. PubMed ID: 28472283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-osteogenic role of interleukin-22 in calcific aortic valve disease.
    Deng H; Li H; Liu Z; Shen N; Dong N; Deng C; Liu F
    Atherosclerosis; 2024 Jan; 388():117424. PubMed ID: 38104486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve.
    Bouchareb R; Mahmut A; Nsaibia MJ; Boulanger MC; Dahou A; Lépine JL; Laflamme MH; Hadji F; Couture C; Trahan S; Pagé S; Bossé Y; Pibarot P; Scipione CA; Romagnuolo R; Koschinsky ML; Arsenault BJ; Marette A; Mathieu P
    Circulation; 2015 Aug; 132(8):677-90. PubMed ID: 26224810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAMTS5 Deficiency in Calcified Aortic Valves Is Associated With Elevated Pro-Osteogenic Activity in Valvular Interstitial Cells.
    Li F; Song R; Ao L; Reece TB; Cleveland JC; Dong N; Fullerton DA; Meng X
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1339-1351. PubMed ID: 28546218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin induces osteoblast differentiation of human valvular interstitial cells via the Akt and ERK pathways.
    Rosa M; Paris C; Sottejeau Y; Corseaux D; Robin E; Tagzirt M; Juthier F; Jashari R; Rauch A; Vincentelli A; Staels B; Van Belle E; Susen S; Dupont A
    Acta Diabetol; 2017 Jun; 54(6):551-560. PubMed ID: 28314924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?
    Broeders W; Bekkering S; El Messaoudi S; Joosten LAB; van Royen N; Riksen NP
    Basic Res Cardiol; 2022 May; 117(1):28. PubMed ID: 35581364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathobiology of Lp(a) in calcific aortic valve disease.
    Mathieu P; Arsenault BJ; Boulanger MC; Bossé Y; Koschinsky ML
    Expert Rev Cardiovasc Ther; 2017 Oct; 15(10):797-807. PubMed ID: 28816078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcific aortic valve disease: mechanisms, prevention and treatment.
    Moncla LM; Briend M; Bossé Y; Mathieu P
    Nat Rev Cardiol; 2023 Aug; 20(8):546-559. PubMed ID: 36829083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-214 promotes the calcification of human aortic valve interstitial cells through the acceleration of inflammatory reactions with activated MyD88/NF-κB signaling.
    Zheng D; Zang Y; Xu H; Wang Y; Cao X; Wang T; Pan M; Shi J; Li X
    Clin Res Cardiol; 2019 Jun; 108(6):691-702. PubMed ID: 30519780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.